← Alert archive

MHRA alerts issued in 2026

95 alerts.

• National Patient Safety Alert: Patient hoists and slings (all types): risk of death and serious harm from falls (NatPSA/2026/005/MHRA)

  16 Sept 2026 · National patient safety alert

• Field Safety Notices: 7 September to 11 September 2026

  7 Sept 2026 · Field safety notice (devices)

• Field Safety Notices: 24 to 28 August 2026

  3 Sept 2026 · Field safety notice (devices)

• Filters should be used during the administration of Parenteral Nutrition for patients in all care settings DSI/2026/011

  2 Sept 2026 · Device safety information

• Field Safety Notices: 31 August to 4 September 2026

  31 Aug 2026 · Field safety notice (devices)

• Cobalt-chrome modular neck hip replacements: risk of metal-wear effects and revision surgery (DSI/2026/010)

  26 Aug 2026 · Device safety information

• MHRA Safety Roundup: August 2026

  25 Aug 2026 · MHRA Safety Roundup

• NGPod pH testing device: quarantine and dispose of all devices (DSI/2026/009)

  24 Aug 2026 · Device safety information

• Class 2 Medicines Recall: Zentiva Pharma UK Limited, Fingolimod Zentiva 0.5 mg Capsules, EL(26)A/37

  20 Aug 2026 · Medicines recall/notification · EL (26)A/37

  Class 2
• Field Safety Notices: 10 to 14 August 2026

  18 Aug 2026 · Field safety notice (devices)

• Rectal catheters sold for personal use (gas and colic relievers): Do not use in infants, including for the treatment of colic, gas-related discomfort or constipation (DSI/2026/008)

  18 Aug 2026 · Device safety information

• National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)

  17 Aug 2026 · National patient safety alert

• Field Safety Notices: 17 to 21 August 2026

  17 Aug 2026 · Field safety notice (devices)

• Field Safety Notices: 3 to 7 August 2026

  11 Aug 2026 · Field safety notice (devices)

• Devices supplied without valid UKCA/CE conformity markings or certification: remove from use and place in quarantine (DSI/2026/007)

  10 Aug 2026 · Device safety information

• Belzer UW® Cold Storage Solution and Belzer MPS® (UW Machine Perfusion Solution): manufactured by Carnamedica (UKRP: Bridge to Life): Updated advice on the contamination of fluid DSI/2026/006 (update to DSI/2023/005)

  6 Aug 2026 · Device safety information

• Field Safety Notices: 27 to 31 July 2026

  4 Aug 2026 · Field safety notice (devices)

• Dräger Atlan Anaesthesia workstations: risk of ventilator failure (DSI/2026/005)

  4 Aug 2026 · Device safety information

• MHRA Safety Roundup: July 2026

  30 Jul 2026 · MHRA Safety Roundup

• Field Safety Notices: 20 to 24 July 2026

  28 Jul 2026 · Field safety notice (devices)

• Class 4 Medicines Defect Notification: Neuraxpharm UK Ltd, Tuzulby prolonged-release chewable tablets, EL(26)A/36

  23 Jul 2026 · Medicines recall/notification · EL (26)A/36

  Class 4
• Field Safety Notices: 13 to 17 July 2026

  21 Jul 2026 · Field safety notice (devices)

• Class 4 Medicines Defect Notification: Macarthys Laboratories Ltd T/A Martindale Pharma, Xaggitin XL Prolonged-release Tablets, EL(26)A/35

  20 Jul 2026 · Medicines recall/notification · EL (26)A/35

  Class 4
• Field Safety Notices: 6 to 10 July 2026

  14 Jul 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Beckton Dickson UK Ltd, ChloraPrep 1mL applicator, EL(26)A/34

  13 Jul 2026 · Medicines recall/notification · EL (26)A/34

  Class 2
• Class 2 Medicines Recall: Bristol Laboratories Limited, Phenoxymethylpenicillin 250 mg/5ml Sugar free Oral Solution BP, EL(26)A/33

  9 Jul 2026 · Medicines recall/notification · EL (26)A/33

  Class 2
• Field Safety Notices: 29 June to 03 July 2026

  6 Jul 2026 · Field safety notice (devices)

• MHRA Safety Roundup: June 2026

  30 Jun 2026 · MHRA Safety Roundup

• Field Safety Notices: 22 to 26 June 2026

  30 Jun 2026 · Field safety notice (devices)

• UPDATE: Class 4 Medicines Defect Notification: Relonchem Limited, Gabapentin Relonchem 50mg/ml Oral Solution, EL(26)A/31

  30 Jun 2026 · Medicines recall/notification · EL (26)A/31

  Class 4
• Class 3 Medicines Recall: Flamingo Pharma UK Ltd, Flucloxacillin Capsules BP 500mg, EL(26)A/32

  30 Jun 2026 · Medicines recall/notification · EL (26)A/32

  Class 3
• Class 4 Medicines Defect Notification: Brancaster Pharma Limited, Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection, EL(26)A/30

  29 Jun 2026 · Medicines recall/notification · EL (26)A/30

  Class 4
• Field Safety Notices: 15 to 19 June 2026

  23 Jun 2026 · Field safety notice (devices)

• Class 3 Medicines Recall: Orbit Pharma Limited, Cyclizine Lactate 50 mg/ml Solution for injection, EL(26)A/29

  16 Jun 2026 · Medicines recall/notification · EL (26)A/29

  Class 3
• Field Safety Notices: 8 -12 June 2026

  15 Jun 2026 · Field safety notice (devices)

• Field Safety Notices: 1-5 June 2026

  8 Jun 2026 · Field safety notice (devices)

• Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28

  8 Jun 2026 · Medicines recall/notification · EL (26)A/28

  Class 4
• Class 4 Medicines Defect Notification: Teva UK Ltd, Ponlimsi (Denosumab) 60mg Solution for Injection in Pre-filled Syringe, EL(26)A/27

  4 Jun 2026 · Medicines recall/notification · EL (26)A/27

  Class 4
• Field Safety Notices: 25 to 29 May 2026

  2 Jun 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Becton Dickinson UK Ltd, ChloraPrep 2% 1mL and ChloraPrep Frepp 2% 1.5mL applicators, EL(26)A/26

  2 Jun 2026 · Medicines recall/notification · EL (26)A/26

  Class 2
• MHRA Safety Roundup: May 2026

  28 May 2026 · MHRA Safety Roundup

• Field Safety Notices: 18 -22 May 2026

  28 May 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 2.5 mg Capsules, EL(26)A/25

  28 May 2026 · Medicines recall/notification · EL (26)A/25

  Class 2
• Allurion Gastric Balloon: Updated safety information due to the risks of gastric outlet obstruction, small bowel obstruction and gastric perforation (DSI/2026/004)

  27 May 2026 · Device safety information

• Risk of severe harm from use of incorrect giving (administration) set for blood transfusion (DSI/2026/003)

  20 May 2026 · Device safety information

• Kimal Procedure Packs containing recalled components: Namic Angiographic Syringe with the risk of syringe disconnection; Namic Manifolds with the risk of foreign particulates. Important guidance for use in urgent procedures where there are no alternatives. (DSI/2026/002)

  19 May 2026 · Device safety information

• Field Safety Notices: 11 to 15 May 2026

  19 May 2026 · Field safety notice (devices)

• Class 4 Medicines Defect Notification: Fresenius Medical Care Deutschland GmbH, balance 2.3% glucose, 1.25 mmol/l calcium, solution for peritoneal dialysis, EL(26)A/24

  14 May 2026 · Medicines recall/notification · EL (26)A/24

  Class 4
• Field Safety Notices: 4 to 8 May 2026

  12 May 2026 · Field safety notice (devices)

• Class 4 Medicines Defect Notification: Milpharm Limited, Loperamide hydrochloride 2 mg Orodispersible Tablets, EL(26)A/23

  11 May 2026 · Medicines recall/notification · EL (26)A/23

  Class 4
• Field Safety Notices: 27 April to 1 May 2026

  5 May 2026 · Field safety notice (devices)

• Field Safety Notices: 1 May 2026

  1 May 2026 · Field safety notice (devices)

• MHRA Safety Roundup: April 2026

  29 Apr 2026 · MHRA Safety Roundup

• Field Safety Notices: 20 to 24 April 2026

  28 Apr 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Amarox Limited, Sertraline 100mg film-coated tablets, EL(26)A/22

  28 Apr 2026 · Medicines recall/notification · EL (26)A/22

  Class 2
• Class 3 Medicines Recall: Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets, EL(26)A/21

  23 Apr 2026 · Medicines recall/notification · EL (26)A/21

  Class 3
• Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20

  22 Apr 2026 · Medicines recall/notification · EL (26)A/20

  Class 4
• Field Safety Notices: 13 to 17 April 2026

  21 Apr 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 10mg capsules, EL(26)A/19

  20 Apr 2026 · Medicines recall/notification · EL (26)A/19

  Class 2
• Field Safety Notices: 6 to 10 April 2026

  13 Apr 2026 · Field safety notice (devices)

• Field Safety Notices: 30 March - 3 April 2026

  8 Apr 2026 · Field safety notice (devices)

• MHRA Safety Roundup: March 2026

  31 Mar 2026 · MHRA Safety Roundup · EL (26)A/18

• Field Safety Notices: 23-27 March 2026

  31 Mar 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Bio Products Laboratory Limited, Rabies, Human normal Immunoglobulin 500IU solution for Injection, EL(26)A/18

  30 Mar 2026 · Medicines recall/notification · EL (26)A/18

  Class 2
• Class 4 Medicines Defect Notification: Sandoz Limited, Apixaban 2.5mg and 5mg Tablets, EL(26)A/17

  26 Mar 2026 · Medicines recall/notification · EL (26)A/17

  Class 4
• Class 4 Medicines Defect Notification: Quadrant Pharmaceuticals Limited, Vesomni 6 mg/0.4 mg modified release tablets , EL(26)A/16

  26 Mar 2026 · Medicines recall/notification · EL (26)A/16

  Class 4
• Field Safety Notices: 16 - 20 March 2026

  24 Mar 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Regent Medical Limited / Mölnlycke Health Care, Hibiwash 500ml, EL(26)A/15

  23 Mar 2026 · Medicines recall/notification · EL (26)A/15

  Class 2
• Field Safety Notices: 9 - 13 March 2026

  17 Mar 2026 · Field safety notice (devices)

• Class 4 Medicines Defect Notification: Baxter Healthcare Corporation, Onkotrone Injection 2 mg/ml concentrate for solution for infusion, EL(26)A/14

  17 Mar 2026 · Medicines recall/notification · EL (26)A/14

  Class 4
• Class 3 Medicines Recall: Bayer Plc, Various Products, EL(26)A/12

  12 Mar 2026 · Medicines recall/notification · EL (26)A/12

  Class 3
• Class 2 Medicines Recall: Rokshaw Limited Trading as Curaleaf Laboratories, Curaleaf Oil [FS] 10mg/ml THC, 10mg/ml CBD (30ml), EL(26)A/13

  12 Mar 2026 · Medicines recall/notification · EL (26)A/13

  Class 2
• Class 2 Medicines Recall: Crescent Pharma Limited, Ramipril 5mg capsules, EL(26)A/11

  6 Mar 2026 · Medicines recall/notification · EL (26)A/11

  Class 2
• Field Safety Notices: 23-27 February 2026

  3 Mar 2026 · Field safety notice (devices)

• Field Safety Notices: 02 to 06 March 2026

  2 Mar 2026 · Field safety notice (devices)

• MHRA Safety Roundup: February 2026

  25 Feb 2026 · MHRA Safety Roundup

• Field Safety Notices: 16-20 February 2026

  24 Feb 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515), KidNaps (Melatonin) 1mg in 1ml Oral Solution, EL(26)A/09

  23 Feb 2026 · Medicines recall/notification · EL (26)A/09

  Class 2
• Field Safety Notices: 09-13 February 2026

  17 Feb 2026 · Field safety notice (devices)

• Class 3 Medicines Recall: Norgine Limited, MOVICOL Ease Citrus Powder for oral solution 13.7 g, EL(26)A/08

  17 Feb 2026 · Medicines recall/notification · EL (26)A/08

  Class 3
• Field Safety Notices: 02-06 February 2026

  10 Feb 2026 · Field safety notice (devices)

• Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07

  4 Feb 2026 · Medicines recall/notification · EL (26)A/07

  Class 3
• Class 2 Medicines Recall: Syri Limited, T/A SyriMed, Baclofen 10mg/5ml Oral Solution, EL(26)A/06

  3 Feb 2026 · Medicines recall/notification · EL (26)A/06

  Class 2
• Field Safety Notices: 26 to 30 January 2026

  2 Feb 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Accord Healthcare Ltd, Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion (1 vial 100mg powder, 1 vial of 3 mL solvent), EL(26)A/05

  2 Feb 2026 · Medicines recall/notification · EL (26)A/05

  Class 2
• National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine), manufactured by Eaststone Limited due to a potential for overdosing, NatPSA/2026/002/MHRA

  29 Jan 2026 · National patient safety alert

  Class 1
• Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04

  28 Jan 2026 · Medicines recall/notification · EL (26)A/04

  Class 4
• MHRA Safety Roundup: January 2026

  27 Jan 2026 · MHRA Safety Roundup

• Field Safety Notices: 19 to 23 January 2026

  27 Jan 2026 · Field safety notice (devices)

• Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w, EL(26)A/03

  27 Jan 2026 · Medicines recall/notification · EL (26)A/03

  Class 4
• Class 3 Medicines Recall: Glenmark Pharmaceuticals Europe Limited, Fingolimod Glenmark 0.5 mg Hard Capsules, EL(26)A/02

  21 Jan 2026 · Medicines recall/notification · EL (26)A/02

  Class 3
• Field Safety Notices: 12 to 16 January 2026

  20 Jan 2026 · Field safety notice (devices)

• Class 2 Medicines Recall: Mercury Pharmaceuticals Ltd, Paliperidone Mercury Pharma prolonged-release suspension for injection in pre-filled syringes, EL(26)A/01

  20 Jan 2026 · Medicines recall/notification · EL (26)A/01

  Class 2
• Field Safety Notices for 05-09 January 2026

  12 Jan 2026 · Field safety notice (devices)

• Field Safety Notices: 29 December 2025 to 2 January 2026

  6 Jan 2026 · Field safety notice (devices)

202620252024202320222021202020192018201720162015201420132012201120102009200820072006200520042003